Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes.

Hao Wu,Zongshi Lu, Runyao Chen, Quanfang Cai, Miaomiao Wang, Liting Zhang,Zhiming Zhu

Frontiers in endocrinology（2023）

引用 0|浏览12

暂无评分

摘要

This study suggests that the combination of AGI, concomitant gastrointestinal diseases, female sex and higher TSH levels are independent risk factors of GSEA of liraglutide treatment in patients with T2DM. Further research is warranted to elucidate these interactions.

查看译文

关键词

gastrointestinal side effects,liraglutide,risk factors,thyroid stimulating hormone,type 2 diabetes mellitus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要